(Budesonide 200 mcg + Formoterol Fumarate Dihydrate 6 mcg)
Metered Dose Inhaler (MDI)
For Oral Inhalation Only
Budesonide IP 200 mcg
Formoterol Fumarate Dihydrate IP 6 mcg
In a pressurized propellant base (CFC-free)
Budeflo 200 Inhaler is a fixed-dose combination of Budesonide, a potent inhaled corticosteroid (ICS), and Formoterol, a long-acting beta-2 adrenergic agonist (LABA). This dual therapy is designed for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Budesonide reduces inflammation in the airways, while Formoterol relaxes bronchial muscles, providing fast and sustained bronchodilation.
Maintenance treatment of persistent asthma
Long-term management of moderate to severe COPD
Reduction of asthma and COPD exacerbations
Dual-action for superior control of chronic airway inflammation and bronchospasm
Provides rapid onset (within minutes) and 24-hour symptom relief
Reduces risk of exacerbations and improves lung function
User-friendly inhaler design ensures accurate and consistent dosing
CFC-free and safe for regular, long-term use
Price: